目的探讨红霉素治疗小儿支气管肺炎的临床效果。方法将我院于2011年1月～2012年6月收治的小儿支气管肺炎患者120例随机分成观察组和对照组,两组在进行常规抗感染、抗病毒及氧疗、气道管理、糖皮质激素等治疗的基础上,观察组加用静滴红霉素30mg/kg,1次/d,14d为一个治疗周期。结果观察组痊愈17例,显效32例,有效7例,总有效率81.7%(17+32/60);对照组痊愈13例,显效25例,有效16例,总有效率63.3%(18+25/60);观察组的临床治疗效果优于对照组。结论红霉素在对小儿支气管肺炎进行临床治疗的过程中具有较好的消炎抗菌功能,并且能够有效减轻支气管扩张加重的临床症状。 Objective To investigate the clinical effect of erythromycin on children with bronchopneumonia. Methods One hundred and twenty cases of children with bronchopneumonia treated in our hospital from January 2011 to June 2012 were randomly divided into observation group and control group. The two groups were treated with conventional anti-infection, antivirus and oxygen therapy, airway management, Hormone and other treatment based on the observation group with intravenous infusion of erythromycin 30mg / kg, 1 / d, 14d for a treatment cycle. Results In the observation group, 17 cases were cured, 32 cases were markedly effective and 7 cases were effective. The total effective rate was 81.7% (17 + 32/60). In the control group, 13 cases were cured, 25 cases were markedly effective and 16 cases were effective. The total effective rate was 63.3% 25/60). The clinical effect of the observation group was better than that of the control group. Conclusion Erythromycin has a good anti-inflammatory and anti-bacterial function in the clinical treatment of bronchial pneumonia in children, and can effectively reduce the clinical symptoms of bronchiectasis.